Literature DB >> 17551160

Rosiglitazone--continued uncertainty about safety.

Jeffrey M Drazen, Stephen Morrissey, Gregory D Curfman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551160     DOI: 10.1056/NEJMe078118

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors:  Kay Dickersin; Iain Chalmers
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

2.  Rosiglitazone: a European regulatory perspective.

Authors:  E Blind; K Dunder; P A de Graeff; E Abadie
Journal:  Diabetologia       Date:  2010-12-14       Impact factor: 10.122

3.  Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-01       Impact factor: 10.122

4.  Drug-related risks.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11       Impact factor: 2.953

5.  Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?

Authors:  N A Hanley
Journal:  Diabetologia       Date:  2007-07-26       Impact factor: 10.122

6.  A problem for achieving informed choice.

Authors:  Adam La Caze
Journal:  Theor Med Bioeth       Date:  2008-09-19

Review 7.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

8.  Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.

Authors:  Walter T Ambrosius; Ronald P Danis; David C Goff; Craig M Greven; Hertzel C Gerstein; Robert M Cohen; Matthew C Riddle; Michael E Miller; John B Buse; Denise E Bonds; Kevin A Peterson; Yves D Rosenberg; Letitia H Perdue; Barbara A Esser; Lea A Seaquist; James V Felicetta; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2010-03

9.  Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).

Authors:  A Ramachandran; C Snehalatha; S Mary; S Selvam; C K S Kumar; A C Seeli; A S Shetty
Journal:  Diabetologia       Date:  2009-03-10       Impact factor: 10.122

Review 10.  American Diabetes Association indications for statins in diabetes: is there evidence?

Authors:  Roy Eldor; Itamar Raz
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.